EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Prevalence of gestational transient thyrotoxicosis and Graves disease in pregnancy



Prevalence of gestational transient thyrotoxicosis and Graves disease in pregnancy



Endocrine Journal 47(Suppl August): 231, August




(PDF emailed within 1 workday: $29.90)

Accession: 035548977

Download citation: RISBibTeXText



Related references

The prevalence of transient thyrotoxicosis after antithyroid drug therapy in patients with Graves' disease. Thyroid 18(1): 63-66, 2008

Is the measurement of inferior thyroid artery blood flow velocity by color-flow Doppler ultrasonography useful for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease? A prospective study. Clinics 67(2): 125-129, 2012

Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?. Endocrine Journal 62(6): 557-560, 2016

Painless thyroiditis and transient thyrotoxicosis after Graves' disease. JAMA 244(12): 1361-1361, 1980

Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. Journal of Clinical Endocrinology and Metabolism 55(1): 108-112, 1982

Measurement of red blood cell zinc concentration with Zn-test kit: discrimination between hyperthyroid Graves' disease and transient thyrotoxicosis. Endocrine Journal 45(6): 767-772, 1999

Prevalance of gestational diabetes mellitus in patients with gestational transient thyrotoxicosis. Gynecological Endocrinology 29(4): 336-339, 2013

Graves disease in pregnancy a risk for the child. Maternal TSH receptor antibodies can cause fetal and neonatal thyrotoxicosis. Lakartidningen 105(3): 120-124, 2008

Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: Correlations with total and free beta human chorionic gonadotrophin. Clinical Endocrinology 55(3): 391-398, September, 2001

Crucial role of serum human chorionic gonadotropin for the aggravation of thyrotoxicosis in early pregnancy in Graves' disease. Thyroid 3(3): 189-193, 1993

Spontaneous transient Graves' thyrotoxicosis. Thyroid 18(10): 1133-1134, 2008

Gestational transient thyrotoxicosis. American Journal of Emergency Medicine 21(6): 506-506, 2003

Prediction of postpartum relapse of Graves' thyrotoxicosis and the development of neonatal Graves' disease by the highly sensitive TSH immunoradiometric assay. Rinsho Byori. Japanese Journal of Clinical Pathology 36(4): 455-458, 1988

A clinical study on gestational transient thyrotoxicosis. Zhonghua Nei Ke Za Zhi 47(12): 1003-1007, 2009